ANAPPHYLAXIS  

Integrated solution for anaphylaxis managment

OWNER

(See Profile)


Sector

Medical device

Stage

Clinical Study

Funding needed

500 000€

Country

Spain

$1B TOTAL ADDRESSABLE MARKET BY 2022

$0.5B REVENUE BY 2022

RESULTS FROM CLINICAL TRIALS ALLOW TO DEFINE 50% MARKET PENETRATION AS AN APPROVED MEDICAL DEVICE

ANAPPHYLAXIS HELPS PATIENTS INCREASE THE ADHERENCE TO THE TREATMENT FROM 65% TO 85%

SUPPORTED BY WORLDWIDE KEY OPINION LEADERS: WORLD ALLERGY ORGANZIATION (WAO) PRESIDENT, EUROPEAN ACADEMY OF ALLERGY (EAACI) VICE PRESIDENT,...

If you want to have more information or you want to review the project, you have to login or register
Contact the entrepreneur
Share your thoughts with other BioExperts

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar